Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide treatment for patients who have relapsed
Non-Hodgkin's lymphoma (NHL) or refractory NHL, and to test the immunity of study subjects
after receiving four treatments with rituximab.